Ossiam Has $1.45 Million Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Ossiam boosted its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 6.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 55,416 shares of the pharmacy operator’s stock after purchasing an additional 3,481 shares during the period. Ossiam’s holdings in Walgreens Boots Alliance were worth $1,447,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of WBA. J.P. Morgan Private Wealth Advisors LLC bought a new stake in shares of Walgreens Boots Alliance in the 3rd quarter valued at about $368,000. Van ECK Associates Corp lifted its position in shares of Walgreens Boots Alliance by 28.2% in the third quarter. Van ECK Associates Corp now owns 129,191 shares of the pharmacy operator’s stock valued at $2,873,000 after buying an additional 28,400 shares during the last quarter. Pathstone Family Office LLC boosted its stake in shares of Walgreens Boots Alliance by 138.4% during the 3rd quarter. Pathstone Family Office LLC now owns 45,833 shares of the pharmacy operator’s stock worth $1,024,000 after acquiring an additional 26,606 shares during the period. Campbell & CO Investment Adviser LLC acquired a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth approximately $376,000. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in Walgreens Boots Alliance by 15.4% in the 3rd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 144,066 shares of the pharmacy operator’s stock valued at $3,204,000 after acquiring an additional 19,172 shares during the period. 58.59% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Inderpal S. Bhandari purchased 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 11th. The shares were bought at an average cost of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, Director Inderpal S. Bhandari purchased 3,000 shares of the company’s stock in a transaction dated Thursday, April 11th. The stock was bought at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the purchase, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Manmohan Mahajan acquired 6,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were purchased at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the acquisition, the chief financial officer now owns 166,969 shares in the company, valued at $3,235,859.22. The disclosure for this purchase can be found here. Insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of Walgreens Boots Alliance stock opened at $15.94 on Tuesday. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. The company has a market cap of $13.75 billion, a PE ratio of -2.28, a price-to-earnings-growth ratio of 0.99 and a beta of 0.78. The company has a 50 day moving average of $17.36 and a 200-day moving average of $20.76. Walgreens Boots Alliance, Inc. has a 1-year low of $14.62 and a 1-year high of $32.89.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last released its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The firm had revenue of $37.05 billion during the quarter, compared to analysts’ expectations of $35.86 billion. During the same period in the prior year, the company earned $1.16 earnings per share. The company’s quarterly revenue was up 6.3% on a year-over-year basis. As a group, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 3.21 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st will be given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 6.27%. The ex-dividend date is Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio is presently -14.29%.

Analysts Set New Price Targets

WBA has been the subject of a number of research analyst reports. UBS Group reduced their price objective on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a research report on Wednesday, April 3rd. Evercore ISI decreased their price target on shares of Walgreens Boots Alliance from $18.00 to $17.00 and set an “in-line” rating on the stock in a research note on Monday, June 3rd. HSBC restated a “reduce” rating and set a $20.00 price objective (down from $27.00) on shares of Walgreens Boots Alliance in a research report on Tuesday, February 20th. Leerink Partnrs reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. Finally, Morgan Stanley reduced their price target on Walgreens Boots Alliance from $16.00 to $13.00 and set an “underweight” rating for the company in a research note on Friday, May 31st. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $23.57.

Read Our Latest Report on WBA

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Stories

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.